Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion type Assertion NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_head.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion evidence source_evidence_literature NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion SIO_000772 18676740 NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion wasDerivedFrom befree-2016 NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.
- NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion wasGeneratedBy ECO_0000203 NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.